Research shows stronger but less frequent drug doses could be key
Researchers in the University of Georgia’s Center for Tropical and Emerging Global Diseases have found that a more intensive, less frequent drug regimen with currently available therapeutics could cure the infection that causes Chagas disease, a potentially life-threatening illness affecting up to 300,000 people in the United States.
Trypanosoma cruzi is a single-celled parasitic organism that causes Chagas disease. At least 6 million people are infected by T. cruzi, mostly in South America. Current drug therapies have been ineffective in completely clearing the infection and are associated with severe adverse side effects.
A single dose of benznidazole has been shown to be highly effective in killing more than 90% of parasites. However, after a CTEGD team found some of the parasites enter into a dormancy stage, the researchers hypothesized that an intermittent treatment schedule could be effective.
Current human trials are only looking at giving lower doses over a shorter time period, which is the exact opposite of what we show works.” — Rick Tarleton
“In this system we can see what a single dose of drug does,” said Rick Tarleton, Regents’ Professor in UGA’s department of cellular biology. “Does it make sense to give a drug twice daily when the remaining dormant parasites are insensitive to it?”
The investigators found that giving as little as two-and-a-half times the typical daily dose of benznidazole, once per week for 30 weeks, completely cleared the infection, whereas giving the standard daily dose once a week for a longer period did not.
“Current human trials are only looking at giving lower doses over a shorter time period, which is the exact opposite of what we show works,” said Tarleton.
Since Tarleton’s team worked with a mouse model, how this change in treatment regimen will translate in humans is yet unknown, as are any potential side effects of the higher doses. Adverse reactions already are a problem with current treatments; the hope is that side effects from a less frequent dosage would be more tolerable.
Significant challenge
Assessing the success of treatments in Chagas disease is a significant challenge. Tissue samples from infected organisms might not be representative of the entire organ or animal, since low numbers of persistent, dormant parasites can be difficult to detect. Therefore, Tarleton’s group used light sheet fluorescence microscopy to view intact whole organs from infected mice.
“With light sheet fluorescence microscopy, you have a broad view of potentially any tissue in the mouse that allows for dependable assessment of parasite load and persistence,” said Tarleton. “It gives you an incredible view of the infection.”
Using this technology, they learned something new about the dormant parasites: Some were still susceptible to drug treatment. This provides hope that new drug therapies could be developed to target these parasites.
“Discovery of new drugs should continue,” Tarleton said. “We still need better drugs.”
Co-led by assistant research scientist Juan Bustamante and research professional Fernando Sanchez in Tarleton’s research group, the study’s findings appear in Science Translational Medicine.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Chagas disease
- Kephera Diagnostics Wins $606K NIH Grant to Develop Test for Congenital Chagas Disease
While the parasitic infection is primarily spread through insect vectors, it can also be transmitted congenitally and is often asymptomatic in newborns.
- Accelerating the Development of a Therapeutic Vaccine for Human Chagas Disease
The studies described above provide a strong preclinical foundation for accelerating the development of a therapeutic human vaccine for Chagas disease. The authors are currently working to produce ...
- Kissing bugs, vector for Chagas disease, successfully gene edited for first time
Kissing bugs, or triatomine bugs, are the primary vector for Chagas disease, a major public health concern in Central and South America and even the southern United States. However, there aren't ...
- What is Chagas disease, an infection caused by 'kissing bugs' affecting 7 million people?
Chagas disease, caused by the protozoan parasite Trypanosoma cruzi, finds its roots in the intricate web of transmission dynamics, affecting around 6-7 million people worldwide, especially in ...
- Chagas Disease: Know causes, symptoms and all about infection caused by 'Kissing Bugs'
The rapidly spreading Chagas disease is causing the death of thousands of people every year around the world. Chagas disease is a disease that is caused by the parasite Trypanosoma cruzi.
Go deeper with Google Headlines on:
Chagas disease
[google_news title=”” keyword=”Chagas disease” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Light sheet fluorescence microscopy
- Leica Microsystems adds Viventis Microscopy to portfolio
Leica Microsystems, a subsidiary of medical device conglomerate Danaher, has added Viventis Microscopy to its portfolio. The company’s Viventis LS2 Live Dual View Light Sheet Fluorescence Microscope ...
- Leica Microsystems adds cutting-edge light sheet solutions to its portfolio with the integration of Viventis Microscopy
Patented Viventis light sheet solution enables detailed volumetric imaging to explore life in its entirety Wetzlar, Germany, May 7, 2024 Leica Microsystems, a leader in microscopy and scientific ...
- Fluorescence Microscopy News and Research
This is the first time that all the proteins of an organism have been tracked across the cell cycle, which required a combination of deep learning and high-throughput microscopy. A team of ...
- New super-resolution microscopy approach visualizes internal cell structures and clusters via selective plane activation
This is the intrinsic limitation on a microscope's ability to focus on ... by selecting only a desired plane to image using thin "light sheet" illumination, projected perpendicular to the lens ...
- A better view with new mid-infrared nanoscopy
super-resolution fluorescent microscopes require specimens to be labeled with fluorescence. This can sometimes be toxic to samples and extended light exposure while viewing can bleach samples ...
Go deeper with Google Headlines on:
Light sheet fluorescence microscopy
[google_news title=”” keyword=”light sheet fluorescence microscopy” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]